title: Development of hollow/porous floating beads of metoprolol for pulsatile drug delivery.
abstract: The purpose of this work was to develop hollow calcium pectinate beads for floating pulsatile release of metoprolol tartrate intended for chronopharmacotherapy. Floating pulsatile concept was applied to increase the gastric residence of the dosage form having lag phase followed by a burst release. To overcome limitations of various approaches for imparting buoyancy, hollow/porous beads were prepared by simple process of acid-base reaction during ionotropic cross-linking using low methoxy pectin, xanthan gum, sodium carboxy methyl cellulose, guar gum, locust bean, gellan gum and calcium chloride as a cross-linking agent. Based on the preliminary studies optimized polymers were selected for formulation design with different polymers ratio concentrations. The obtained floating beads were studied for entrapment efficiency, buoyancy study, swelling index, surface morphology, in vitro release, stability studies and in vivo floating study. The floating beads obtained were porous, float up to 12-24 h. The radiological studies (X-rays) pointed out the capability of the system to release drug in lower parts of GIT after a programmed lag time for hypertension. The floating beads provided expected two-phase release pattern with initial lag time during floating in acidic medium followed by rapid pulse release in phosphate buffer. From the accelerated stability studies, it was observed that the formulations are quite stable. All formulations followed first-order release kinetics by diffusion mechanism. This approach suggested the use of hollow calcium pectinate microparticles as promising floating pulsatile drug delivery system for site- and time-specific release of drugs acting as per chronotherapy of diseases.
authors.affiliation: Department of Pharmaceutics, KLEU's College of Pharmacy, Belgaum, 590010, Karnataka, India, sangamesh369@yahoo.com.
authors.forename: Sangmesh S
authors.initials: SS
authors.lastname: Taranalli
authors.forename: Panchaxari M
authors.initials: PM
authors.lastname: Dandagi
authors.forename: Vinayak S
authors.initials: VS
authors.lastname: Mastiholimath
mesh_terms: D000818:Animals; D002626:Chemistry, Pharmaceutical; D016503:Drug Delivery Systems; D004355:Drug Stability; D008790:Metoprolol / Q000008:administration & dosage* / Q000737:chemistry; D010316:Particle Size; D016062:Porosity; D011817:Rabbits; D012995:Solubility
chemical_list: D008790:Metoprolol
references.citation: Pharm Res. 1987 Feb;4(1):70-4
references.pmid: 3508533
references.citation: Eur J Pharm Biopharm. 2011 Nov;79(3):566-73
references.pmid: 21664462
references.citation: Eur J Pharm Sci. 2005 Mar;24(4):363-73
references.pmid: 15734303
references.citation: J Microencapsul. 1999 May-Jun;16(3):303-13
references.pmid: 10340216
references.citation: Int J Pharm. 2000 Apr 5;198(2):157-65
references.pmid: 10767565
references.citation: Colloids Surf B Biointerfaces. 2012 Jan 1;89:182-7
references.pmid: 21974910
references.citation: Acta Pharm. 2007 Dec;57(4):413-27
references.pmid: 18165186
references.citation: Int J Pharm. 2011 Jul 29;414(1-2):28-34
references.pmid: 21601627
references.citation: Int J Pharm. 2012 Jan 17;422(1-2):211-9
references.pmid: 22093955
references.citation: J Control Release. 2003 Dec 12;93(3):331-9
references.pmid: 14644583
references.citation: J Control Release. 2010 Nov 1;147(3):314-25
references.pmid: 20691738
references.citation: J Microencapsul. 2008 Aug;25(5):307-14
references.pmid: 18465300
references.citation: Int J Pharm. 2000 Dec 4;210(1-2):45-9
references.pmid: 11163986
references.citation: Drug Dev Ind Pharm. 2006 Aug;32(7):847-55
references.pmid: 16908422